These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 20687967)
1. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Kim TH; Chung KW; Lee YJ; Park CS; Lee EK; Kim TS; Kim SK; Jung YS; Ryu JS; Kim SS; Cho KH; Shin KH Radiat Oncol; 2010 Aug; 5():69. PubMed ID: 20687967 [TBL] [Abstract][Full Text] [Related]
2. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience. Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097 [TBL] [Abstract][Full Text] [Related]
3. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era. Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725 [TBL] [Abstract][Full Text] [Related]
4. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer. Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803 [TBL] [Abstract][Full Text] [Related]
5. Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience. Besic N; Dremelj M; Pilko G Radiol Oncol; 2018 Sep; 52(4):453-460. PubMed ID: 30244234 [TBL] [Abstract][Full Text] [Related]
6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244 [TBL] [Abstract][Full Text] [Related]
7. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer. Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274 [TBL] [Abstract][Full Text] [Related]
8. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse]. Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902 [TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926 [TBL] [Abstract][Full Text] [Related]
10. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Schwartz DL; Lobo MJ; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Evans DB; Clayman G; Sherman SI; Garden AS Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1083-91. PubMed ID: 19095376 [TBL] [Abstract][Full Text] [Related]
11. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796 [TBL] [Abstract][Full Text] [Related]
12. External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control? Cavalcante LBCP; Treistman N; Gonzalez FMTT; Fernandes PIW; Alves Junior PAG; Andrade FA; Ferreira EN; Brito TF; Pane A; Corbo R; Erlich F; Bulzico DA; Vaisman F Head Neck; 2024 Jun; 46(6):1340-1350. PubMed ID: 38445804 [TBL] [Abstract][Full Text] [Related]
13. Value of external irradiation for locally advanced papillary thyroid cancer. Kim TH; Yang DS; Jung KY; Kim CY; Choi MS Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1006-12. PubMed ID: 12605980 [TBL] [Abstract][Full Text] [Related]
14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196 [TBL] [Abstract][Full Text] [Related]
15. Indications of external beams radiation for thyroid cancer. Roukoz C; Gregoire V Curr Opin Otolaryngol Head Neck Surg; 2022 Apr; 30(2):137-144. PubMed ID: 35152242 [TBL] [Abstract][Full Text] [Related]
16. Radiotherapy in well-differentiated thyroid cancer: is it underutilized? So K; Smith RE; Davis SR ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999 [TBL] [Abstract][Full Text] [Related]
17. Results of external beam radiotherapy in patients with well differentiated thyroid carcinoma. Lin JD; Tsang NM; Huang MJ; Weng HF Jpn J Clin Oncol; 1997 Aug; 27(4):244-7. PubMed ID: 9379512 [TBL] [Abstract][Full Text] [Related]
18. The Role of postoperative external beam radiotherapy for differentiated thyroid carcinoma: A Systematic review and meta-analysis. Jacomina LE; Jacinto JKM; Co LBA; Yu KKL; Agas RAF; Co JL; Mejia MBA Head Neck; 2020 Aug; 42(8):2181-2193. PubMed ID: 32129545 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma--a retrospective review of 182 cases. Yang TS; Ng KT; Wang HM; Wang CH; Liaw CC; Lai GM Am J Clin Oncol; 1996 Aug; 19(4):337-43. PubMed ID: 8677900 [TBL] [Abstract][Full Text] [Related]
20. The role of external beam radiation therapy in well-differentiated thyroid cancer. Hamilton SN; Tran E; Berthelet E; Wu J Expert Rev Anticancer Ther; 2017 Oct; 17(10):905-910. PubMed ID: 28750593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]